Which of the following drugs may result in a 'seal limb' deformity in a newborn?
Respiratory centre depression is caused by all the following drugs except:
Extracellular adenosine is increased by which of the following DMARDs?
A 28-year-old farmer is found convulsing in the farm. His heart rate is 100/min and blood pressure is 180/110 mm Hg. He has diarrhea, sweating, and urination. His pupils are pinpoint. Drug poisoning is suspected. What is the most probable cause?
Which of the following monoclonal antibodies is a humanized antibody?
Use of ergotamine is contraindicated in which of the following conditions?
Peripheral neuropathy is caused by which of the following drugs?
All are true of organophosphate poisoning, except?
All of the following cause macrocytic anemia, except?
Amatoxins in mushroom poisoning act by inhibiting which of the following?
Explanation: The correct answer is **Thalidomide**. **Thalidomide** is a notorious teratogen that was used in the late 1950s as a sedative and anti-emetic for morning sickness. Its use led to a disaster characterized by **Phocomelia** (derived from the Greek word *phoke* meaning "seal" and *melos* meaning "limb"). This condition involves the long bones of the limbs being absent or severely underdeveloped, causing the hands or feet to be attached directly to the trunk, resembling a **"seal limb."** The critical period of exposure is between the 24th and 36th days of gestation [1]. **Analysis of Incorrect Options:** * **Diethylstilbestrol (DES):** Exposure in utero is associated with **Clear Cell Adenocarcinoma of the vagina** and cervix in female offspring later in life, as well as structural abnormalities of the uterus (T-shaped uterus). * **Valproate:** This anti-epileptic drug is primarily associated with **Neural Tube Defects** (e.g., Spina Bifida) due to interference with folate metabolism [1, 2]. * **Progestins:** High doses during pregnancy can lead to the **virilization** (masculinization) of a female fetus [2]. **NEET-PG High-Yield Pearls:** * **Mechanism:** Thalidomide causes limb defects by inhibiting **angiogenesis** and interfering with the protein **Cereblon**, which is essential for limb development. * **Current Uses:** Despite its teratogenicity, Thalidomide is currently used under strict regulation (REMS program) for **Multiple Myeloma** and **Erythema Nodosum Leprosum (ENL)**. * **Warfarin:** Another common "limb" related teratogen, but it causes **Chondrodysplasia punctata** (stippled epiphyses) and nasal hypoplasia, not phocomelia.
Explanation: **Explanation:** The respiratory center in the medulla is highly sensitive to drugs that modulate inhibitory and excitatory neurotransmission. **Strychnine (Correct Answer):** Strychnine is a potent spinal stimulant. Its mechanism of action involves **competitive antagonism of Glycine**, the primary inhibitory neurotransmitter in the spinal cord and brainstem. By blocking glycine receptors, strychnine removes post-synaptic inhibition, leading to over-excitation of neurons. This results in generalized muscle spasms and convulsions. Importantly, death from strychnine poisoning occurs due to **asphyxia** caused by sustained spasms of the diaphragm and thoracic muscles, rather than central respiratory depression. **Incorrect Options:** * **Opium:** Opioids (like Morphine) are classic respiratory depressants. They act on **mu-opioid receptors** in the medullary respiratory center, reducing its sensitivity to carbon dioxide ($CO_2$). * **Barbiturates:** These are CNS depressants that enhance GABAergic transmission. In high doses, they directly depress the medullary respiratory center and the aortic/carotid chemoreceptors. * **Gelsemium:** Derived from the "Yellow Jasmine," it contains alkaloids like gelsemine that act as potent CNS depressants, leading to respiratory failure via central depression. **NEET-PG High-Yield Pearls:** * **Strychnine Poisoning:** Characterized by *Risus Sardonicus* (grimace) and *Opisthotonus* (archback), mimicking Tetanus. However, in Strychnine poisoning, muscles relax between convulsions, whereas in Tetanus, they remain rigid. * **Antidote for Opioids:** Naloxone (Pure antagonist). * **Antidote for Benzodiazepines:** Flumazenil (Note: Barbiturates do not have a specific pharmacological antagonist).
Explanation: **Explanation:** **Methotrexate (MTX)**, the "anchor drug" for Rheumatoid Arthritis, exerts its anti-inflammatory effects primarily through the **adenosine pathway** [1]. While its anti-neoplastic effect is due to dihydrofolate reductase (DHFR) inhibition, its low-dose anti-rheumatic effect is attributed to the inhibition of **AICAR transformylase**. This leads to the intracellular accumulation of AICAR, which inhibits adenosine deaminase, resulting in the release of **adenosine** into the extracellular space [1]. Extracellular adenosine acts on **A2A receptors** to suppress the release of pro-inflammatory cytokines (TNF-α, IL-1) and inhibit neutrophil adhesion. **Analysis of Incorrect Options:** * **Leflunomide:** Acts by inhibiting **dihydroorotate dehydrogenase (DHODH)**, an enzyme essential for *de novo* pyrimidine synthesis [3]. This arrests activated T-cells in the G1 phase. * **Sulphasalazine:** A prodrug cleaved by colonic bacteria into sulfapyridine and 5-ASA [1]. Its mechanism involves scavenging free radicals and inhibiting prostaglandin synthesis; it does not significantly modulate adenosine levels. * **Hydroxychloroquine:** Primarily acts by increasing intracellular pH in endosomes/lysosomes, thereby interfering with **antigen presentation** and inhibiting TLR signaling. **NEET-PG High-Yield Pearls:** * **MTX Toxicity Rescue:** Leucovorin (Folinic acid) is used to "rescue" normal cells from MTX toxicity [2]. * **Monitoring:** MTX requires regular monitoring of LFTs (due to risk of hepatic fibrosis) and CBC (due to myelosuppression) [2]. * **Pregnancy:** MTX and Leflunomide are strictly **contraindicated** (Category X) [2]. * **Leflunomide Washout:** Due to its long half-life (2 weeks), **Cholestyramine** is used to enhance its excretion if toxicity occurs or pregnancy is planned [3].
Explanation: ### Explanation **Correct Answer: C. Organophosphate poisoning** The clinical presentation is a classic case of **Organophosphate (OP) poisoning**, which occurs due to the irreversible inhibition of the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors. The patient exhibits the **DUMBELS** mnemonic for muscarinic overstimulation: **D**iarrhea, **U**rination, **M**iosis (pinpoint pupils), **B**ronchospasm/Bradycardia, **E**mesis, **L**acrimation, and **S**alivation/Sweating. While bradycardia is common, **tachycardia and hypertension** (as seen here) can occur due to nicotinic stimulation in the sympathetic ganglia. Convulsions (CNS effects) and the patient’s occupation (farmer) further support this diagnosis. **Why the other options are incorrect:** * **A. Acetaminophen overdose:** Presents primarily with hepatic necrosis (nausea, vomiting, jaundice, and elevated ALT/AST). It does not cause miosis or cholinergic symptoms. * **B. Amphetamine toxicity:** A sympathomimetic toxidrome. While it causes hypertension, tachycardia, and sweating, it presents with **mydriasis (dilated pupils)** and agitation, not pinpoint pupils or diarrhea. * **C. Atropine poisoning:** An anticholinergic toxidrome characterized by the "Red as a beet, Dry as a bone, Blind as a bat, Mad as a hatter" presentation. It causes **mydriasis** and decreased secretions (dry skin/mouth), the opposite of this patient. **NEET-PG High-Yield Pearls:** * **Management:** Atropine (reverses muscarinic effects) and Pralidoxime/2-PAM (reactivates AChE if given before "aging" occurs). * **Monitoring Atropinization:** The best parameter to monitor is the **clearing of bronchial secretions**, not pupil size. * **Intermediate Syndrome:** Occurs 24–96 hours after OP poisoning, characterized by proximal muscle weakness and respiratory failure.
Explanation: To answer this question correctly, one must understand the **nomenclature of monoclonal antibodies (mAbs)**, where the suffix or "infix" indicates the source of the antibody. ### **Explanation of the Correct Answer** **B. Palivizumab** is a **humanized** monoclonal antibody. In nomenclature, the infix **"-zu-"** (as in Pali-**zu**-mab) denotes a humanized antibody. These are engineered by grafting murine hypervariable regions (CDRs) onto a human antibody framework, resulting in a molecule that is approximately 95% human. * **Clinical Use:** It is used for the prevention of Respiratory Syncytial Virus (RSV) infections in high-risk infants. ### **Analysis of Incorrect Options** * **A. Rituximab & C. Infliximab:** These are **chimeric** antibodies. The infix **"-xi-"** (Ritu-**xi**-mab, Infli-**xi**-mab) indicates they are roughly 65% human and 35% murine. Rituximab targets CD20 on B-cells, while Infliximab targets TNF-α. * **D. Basiliximab:** This is also a **chimeric** antibody (**"-xi-"**). It is an IL-2 receptor antagonist used to prevent acute organ rejection in renal transplants. ### **High-Yield Clinical Pearls for NEET-PG** Memorizing the nomenclature infixes is a high-yield strategy for pharmacology questions: 1. **-omab:** 100% Murine (Mouse) source (e.g., Muromonab). Highest risk of hypersensitivity. 2. **-ximab:** Chimeric (e.g., Rituximab, Cetuximab). 3. **-zumab:** Humanized (e.g., Trastuzumab, Bevacizumab). 4. **-umab:** 100% Human (e.g., Adalimumab, Panitumumab). Lowest risk of immunogenicity. **Mnemonic:** **X**i = Mi**x**ed (Chimeric); **Zu** = Humani**z**ed; **U** = P**u**rely Human.
Explanation: **Explanation:** **Ergotamine** is an ergot alkaloid that acts as a potent, non-selective agonist at **5-HT1B/1D receptors**. Its primary therapeutic effect in migraine management is mediated through **intense peripheral and cranial vasoconstriction**. **1. Why Ischemic Heart Disease (IHD) is the Correct Answer:** The vasoconstrictive action of ergotamine is not limited to cranial vessels; it also affects the coronary arteries. In patients with IHD, ergotamine can precipitate **coronary vasospasm**, leading to myocardial ischemia, angina, or even myocardial infarction. Therefore, it is strictly contraindicated in IHD, peripheral vascular disease (Raynaud's), and uncontrolled hypertension. **2. Analysis of Incorrect Options:** * **Diabetes Mellitus:** While DM is a risk factor for vascular disease, it is not a direct contraindication unless the patient has documented macrovascular complications (like CAD or PVD). * **Anemia:** There is no direct pharmacological interaction or contraindication between ergotamine use and anemia. * **Postpartum Hemorrhage (PPH):** Ergot derivatives (specifically **Methylergometrine**) are actually *indicated* in PPH to promote uterine contraction. While ergotamine itself is not the first-line ergot for PPH, it is not contraindicated. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** 5-HT1B/1D agonist → Vasoconstriction + inhibition of neurogenic inflammation. * **Ergotism (St. Anthony’s Fire):** Toxicity characterized by severe peripheral ischemia (gangrene) and CNS stimulation (hallucinations). * **Drug Interaction:** Ergotamine metabolism is inhibited by **CYP3A4 inhibitors** (e.g., Ritonavir, Erythromycin), which can lead to life-threatening ischemia. * **Triptans vs. Ergots:** Both are contraindicated in IHD due to coronary vasoconstriction.
Explanation: **Explanation:** The question asks for the drug that **does NOT** typically cause peripheral neuropathy (assuming the checkmark indicates the intended "except" or "incorrectly associated" option in a standard NEET-PG format, as Digitalis is famously associated with visual and cardiac toxicities rather than nerve damage). **1. Why Digitalis is the Correct Answer (The Exception):** Digitalis (Digoxin) toxicity primarily manifests as **gastrointestinal symptoms** (nausea, vomiting), **cardiac arrhythmias** (most common being PVCs; most characteristic being PAT with block), and **visual disturbances** (Xanthopsia or yellow-green halos). It does not cause peripheral neuropathy. **2. Analysis of Incorrect Options (Drugs that DO cause Neuropathy):** * **Isoniazid (INH):** A classic cause of peripheral neuropathy. It inhibits the enzyme pyridoxine kinase, leading to a deficiency of **Vitamin B6**. This is prevented by co-administering 10–50 mg of Pyridoxine. * **Amiodarone:** This Class III antiarrhythmic is associated with various toxicities, including "stocking-glove" peripheral neuropathy, pulmonary fibrosis, and thyroid dysfunction. * **Thalidomide:** Used in leprosy and multiple myeloma, it is notorious for causing irreversible peripheral sensory neuropathy in addition to its teratogenic effects (phocomelia). **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Peripheral Neuropathy:** "**S**aturday **N**ight **P**alsy **L**eads **T**o **I**nferior **C**onduction" (**S**tavudine, **N**itrofurantoin, **P**aclitaxel/Phenytoin, **L**inezolid, **T**halidomide, **I**soniazid, **C**isplatin/Cyclosporine). * **Vinca Alkaloids:** Vincristine is the most common chemotherapeutic agent to cause peripheral neuropathy (presents as foot drop). * **Ethambutol:** Primarily causes optic neuritis (red-green color blindness), not peripheral neuropathy.
Explanation: ### Explanation **1. Why Option C is the Correct Answer (The "Except" Statement):** Organophosphate (OP) poisoning leads to an accumulation of Acetylcholine (ACh) at both **muscarinic** and **nicotinic** receptors. Atropine is a competitive **muscarinic antagonist**. While it effectively reverses life-threatening "wet" symptoms (salivation, lacrimation, bradycardia, bronchospasm), it has **no effect on nicotinic receptors** located at the neuromuscular junction (NMJ). Therefore, Atropine cannot reverse muscle weakness, fasciculations, or paralysis. To address nicotinic effects, **Oximes** (like Pralidoxime) are required to reactivate the acetylcholinesterase enzyme. **2. Analysis of Other Options:** * **Option A (True):** OPs are irreversible anti-cholinesterase agents. They bind to the active site of the acetylcholinesterase enzyme, preventing the breakdown of ACh. * **Option B (True):** Bradycardia is a classic muscarinic (M2) effect of ACh excess on the heart. (Note: Tachycardia can occasionally occur due to sympathetic ganglionic stimulation, but bradycardia is the textbook description). * **Option D (True):** Paralysis can occur in three phases: **Type I** (Acute cholinergic crisis), **Type II** (Intermediate Syndrome, occurring 24–96 hours later due to NMJ dysfunction), and **Type III** (OP-induced delayed polyneuropathy/OPIDP due to inhibition of Neuropathy Target Esterase). **Clinical Pearls for NEET-PG:** * **Management Goal:** Atropine is titrated until **"Atropinization"** occurs (clearing of lung secretions and increased heart rate), NOT pupil dilation. * **Aging Phenomenon:** Oximes must be administered early. Once the enzyme-OP complex "ages" (dealkylation), oximes can no longer reactivate the enzyme. * **Mnemonic for Muscarinic Symptoms:** **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation).
Explanation: **Explanation:** The correct answer is **Primaquine**. **1. Why Primaquine is the correct answer:** Primaquine is an antimalarial drug that causes **oxidative stress** in red blood cells. In individuals with **G6PD deficiency**, this leads to **acute hemolytic anemia** (normocytic anemia), characterized by Heinz bodies and bite cells. It does not interfere with DNA synthesis or folate metabolism, which are the primary drivers of macrocytosis. **2. Why the other options are incorrect:** Macrocytic anemia (specifically megaloblastic anemia) is caused by drugs that interfere with DNA synthesis, usually by inhibiting folate or vitamin B12 pathways: * **Methotrexate:** A potent **dihydrofolate reductase (DHFR) inhibitor**. It prevents the conversion of dihydrofolate to tetrahydrofolate, directly causing megaloblastic macrocytic anemia. * **Trimethoprim:** Also a **DHFR inhibitor** (though with higher affinity for bacterial enzymes). Prolonged use or use in high-risk patients can lead to folate deficiency and macrocytosis. * **Azathioprine:** A purine analogue (antimetabolite) that interferes with **DNA synthesis**. Bone marrow suppression and macrocytosis are well-known side effects of thiopurines. **3. NEET-PG High-Yield Clinical Pearls:** * **Common causes of Drug-induced Macrocytosis:** Phenytoin, Valproate, Zidovudine (AZT), Hydroxyurea, 5-Fluorouracil, and Methotrexate. * **Primaquine Pearl:** Always screen for **G6PD levels** before administration to prevent life-threatening hemolysis. It is the drug of choice for radical cure of *P. vivax* and *P. ovale* (acting on hypnozoites). * **Rescue Therapy:** Folinic acid (Leucovorin) is used to "rescue" bone marrow from Methotrexate toxicity, bypassing the inhibited DHFR enzyme.
Explanation: **Explanation:** **Mechanism of Action (Why B is correct):** Amatoxins (primarily **α-amanitin**), found in mushrooms like *Amanita phalloides* (Death Cap), are potent inhibitors of **RNA Polymerase II**. This enzyme is responsible for the synthesis of **messenger RNA (mRNA)** in eukaryotic cells. By binding to RNA Polymerase II, amatoxins halt the transcription process, leading to a cessation of protein synthesis and subsequent cell death (apoptosis). The liver is the primary organ affected because it is the first site of toxin concentration after intestinal absorption. **Analysis of Incorrect Options:** * **A. DNA:** While amatoxins affect the transcription process involving DNA, they do not directly inhibit or damage the DNA molecule itself; they target the enzyme responsible for reading it. * **C. Adenosine:** Amatoxins do not interfere with adenosine or its receptors. This option is unrelated to the pathophysiology of mushroom poisoning. * **D. G-proteins:** G-proteins are involved in signal transduction. Toxins like Cholera or Pertussis target G-proteins, but amatoxins do not. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Characterized by a "latent period" (6–24 hours) followed by severe GI symptoms, and eventually **fulminant hepatic failure** (elevated ALT/AST) and renal failure. * **Diagnosis:** Detection of amanitin in urine or gastric aspirate. * **Treatment:** No specific antidote exists, but **Silibinin** (from milk thistle) and **N-acetylcysteine** are used. Silibinin works by competing with the toxin for transmembrane transport into hepatocytes. * **Key Association:** Remember: **Amanitin = RNA Polymerase II = mRNA inhibition.**
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free